CreditReports.dk
HomeScreen companies

REPONEX PHARMACEUTICALS A/S Financials, key figures and credit report

CVR number: 30082346 Established 2006 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Slotsmarken 12, 2970 Hørsholm www.reponex.dk
Gross profit — FY 2025
EBIT -7 693.0 kDKK FY 2025 +43% vs 2024
Net debt -54.0 kDKK FY 2025 -100.6% vs 2024
Quick ratio 3.0 FY 2025 +2.7 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit
Costs of management-5 780.00-7 518.00-4 505.00-2 569.00
Other operating expenses-12 603.84-5 497.00-8 820.00-9 002.00-5 124.00
EBIT-12 603.84-11 277.00-16 338.00-13 507.00-7 693.00
Other financial income0.0366.009.00195.00
Other financial expenses- 250.77-22.00-45.00- 260.00- 104.00
Pre-tax profit-12 854.58-11 299.00-16 317.00-13 758.00-7 603.00
Income taxes2 971.421 855.002 233.001 815.001 033.00
Net earnings-9 883.16-9 444.00-14 084.00-11 943.00-6 570.00

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible rights13 355.5913 860.00
Intangible assets total13 355.5913 860.00
Other tangible assets320.54582.0055.0037.00637.00
Tangible assets total320.54582.0055.0037.00637.00
Other non-current investments451.00234.00
Investments total451.00234.00
Long term receivables total
Inventories total1 160.86
Current owed by particip. interest comp.1 416.002 901.00
Prepayments and accrued income22.561 587.00423.00813.00579.00
Current other receivables961.90802.001 547.00287.00282.00
Current deferred tax assets1 483.481 855.002 233.001 815.002 848.00
Short term receivables total2 467.944 244.005 619.002 915.006 610.00
Cash and bank deposits11 403.252 830.001 938.00445.0054.00
Cash and cash equivalents11 403.252 830.001 938.00445.0054.00
Balance sheet total (assets)28 708.1821 516.008 063.003 631.007 301.00

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital829.54830.00850.00850.00850.00
Other reserves9 958.6818 081.002 308.00-9 635.003 795.00
Retained earnings26 466.179 444.0014 084.0011 943.006 570.00
Profit of the financial year-9 883.16-9 444.00-14 084.00-11 943.00-6 570.00
Shareholders equity total27 371.2318 911.003 158.00-8 785.004 645.00
Non-current leasing loans162.64295.00234.00421.00
Non-current liabilities total162.64295.00234.00421.00
Current leasing loans286.00217.00234.00216.00
Current trade creditors745.681 606.002 659.001 511.00925.00
Current owed to group member9 404.00
Other non-interest bearing current liabilities428.62418.001 795.001 267.001 093.00
Current liabilities total1 174.302 310.004 671.0012 416.002 234.00
Balance sheet total (liabilities)28 708.1721 516.008 063.003 631.007 300.00
Page generated